Thermomind

Early-stage Breast Cancer Detection

Startup

Thermomind is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2022. Early-stage Breast Cancer Detection. The company has raised a total of $12.62M across 2 funding rounds, currently at the Pre-Seed stage. Thermomind was founded by Najeeb Ayoub and Larisa Adamyan. The company has 1-10 employees. Core technologies: Artificial Intelligence, Sensing, Infrared.

With $12.62M in total funding, Thermomind is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2G business model. Product stage: Clinical Trial. The company holds 1 patent.

$12.62M
Raised
2
Rounds
2
Team
2022
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics DevicesArtificial IntelligenceSensingInfrared
At a Glance
Founders
In the News

6 articles covered by sources including www.israel21c.org, www.jpost.com, www.themarker.com, www.ynetnews.com, mobile.mako.co.il.

www.israel21c.org · Apr 28, 2023
Cancer screening: Dr. Larisa Adamyan & Najeeb Ayoub - ISRAEL21c
Read article ↗
Frequently Asked Questions
What does Thermomind do?

ThermoMind is a cutting-edge technology company that is revolutionizing the healthcare industry by offering advanced thermal imaging solutions. Using the latest in thermal sensing technology and artificial intelligence, the company is dedicated to providing highly accurate and reliable imaging technologies that can help doctors and medical professionals make more informed decisions about patient care. The company develops medical devices with customized, highly sensitive thermal sensing hardware and combines with sophisticated AI system to analyze thermal data and identify potential health issues in patients. Whether it's for early disease detection, real-time monitoring, or ongoing patient care, the company's imaging solutions offer unparalleled accuracy and reliability. The current target of the company is transforming the way breast cancer is detected and diagnosed, by a next-generation non-contact and radiation-free screening modality for breast cancer detection. The core of the technology is the advanced AI analysis which is set to identify metabolic abnormalities within the breast indicating breast cancer. The startup's screening modality is designed to be highly scalable, efficient, and cost-effective, making it accessible to a wide range of patients and healthcare providers. By eliminating the need for radiation and contact-based screening methods, the company's technology offers a safer and more comfortable screening experience for patients, while also reducing the risk of false positives and unnecessary biopsies.

How much funding has Thermomind raised?

Thermomind has raised $12.62M in total funding across 2 rounds. The company is currently at the Pre-Seed stage.

Who founded Thermomind?

Thermomind was founded in 2022 by Najeeb Ayoub (Co-founder & CEO), Larisa Adamyan (Co-founder & COO).

What sector is Thermomind in?

Thermomind operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Devices, Diagnostics Devices, with core technologies in Artificial Intelligence, Sensing, Infrared. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients.

Where is Thermomind located?

Thermomind is based in Ha-Namal St 33, Haifa, Israel, North District.

View Full Profile Classic View Website ↗